These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21595512)

  • 1. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
    Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
    Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y receptor interactions regulate its mitogenic activity.
    Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
    Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
    Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
    Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
    Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
    Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/β-catenin pathway in vitro.
    Wu J; Liu S; Meng H; Qu T; Fu S; Wang Z; Yang J; Jin D; Yu B
    Stem Cell Res; 2017 May; 21():74-84. PubMed ID: 28411439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
    Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
    Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.
    Dietrich P; Wormser L; Fritz V; Seitz T; De Maria M; Schambony A; Kremer AE; Günther C; Itzel T; Thasler WE; Teufel A; Trebicka J; Hartmann A; Neurath MF; von Hörsten S; Bosserhoff AK; Hellerbrand C
    J Clin Invest; 2020 May; 130(5):2509-2526. PubMed ID: 31999643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
    Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
    Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of neuropeptide Y-mediated heart innervation in rats.
    Masliukov PM; Moiseev K; Emanuilov AI; Anikina TA; Zverev AA; Nozdrachev AD
    Neuropeptides; 2016 Feb; 55():47-54. PubMed ID: 26589184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
    Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
    Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
    Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
    PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
    Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age related changes of neuropeptide Y-ergic system in the rat duodenum.
    Budnik AF; Aryaeva D; Vyshnyakova P; Masliukov PM
    Neuropeptides; 2020 Apr; 80():101982. PubMed ID: 31708113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
    Yokosuka M; Dube MG; Kalra PS; Kalra SP
    Peptides; 2001 Mar; 22(3):507-14. PubMed ID: 11287108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
    Hsieh YS; Kuo MH; Chen PN; Kuo DY
    Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.